Clostridioides difficile Infection (CDI)
This study is exploring an investigational drug to restore the microbiome (the bacteria that live in your gut) in people with recurrent Clostridioides difficile infection (CDI).
What is CDI?
CDI is an infection of the large bowel (a part of your digestive system) caused by the bacteria Clostridioides difficile. Symptoms include diarrhea, stomach pain, nausea, vomiting, fever, and weight loss.
We are looking for people who:
- Are at least 12 years of age and who are currently experiencing an episode of CDI.
- Have had at least 1 previous CDI episode (before the current one) within the last 6 months.
AND
This Study has successfully completed Phase 1 and Phase 2 studies, and now on Phase 3, which is the final phase before approval. This study is being conducted at multiple study centers in a number of countries worldwide.
As a participant, you will receive extensive information about your health, and the researchers hope the Study will provide valuable clinical information that could help provide improved treatment options for people with CDI in the future.
To participate in this Study, please enroll here.
Are you interested in contributing to the enhancement of human health and welfare? Provide your contact details below, and a member of our site team will reach out to discuss how you can participate in our currently enrolling studies.